Rubin Steven D 4

What Happened
Steven D. Rubin, a director of Entera Bio Ltd. (ENTX), acquired 10,000 common shares on February 9, 2026 at $1.20 per share, for a total cash outlay of $12,000. The Form 4 reports the transaction as a purchase (transaction code P), indicating an acquisition rather than a sale.

Key Details

• Transaction date: 2026-02-09; Form 4 filed: 2026-02-11 (filed within the normal reporting window).
• Price and size: 10,000 shares at $1.20/share — total value $12,000.
• Transaction type: Purchase (code P) — described as open-market or private purchase on the filing.
• Shares owned after transaction: not specified in the summary provided.
• Footnotes/plans: No 10b5‑1 plan, tax withholding, or other footnotes disclosed in the information provided.

Context
Purchases by officers or directors can be more informative than sales because they represent an acquisition of stock; however, this was a relatively small transaction ($12k), which limits how much weight investors typically assign to it. The filing appears timely (filed two days after the trade), and no additional conditions or derivative actions were reported.